UNIVERCELLS
Kate Antrobus, CFA, is a seasoned professional with extensive experience in business leadership and finance within the global health sector. Currently serving as Chief Business Officer, Chief Investment Officer, and Global Health & Finance Lead at UNIVERCELLS since October 2019, Kate also contributes to multiple organizations as a Member of the Board of Trustees for Campaigns in Global Health and a Board Member for Medicines Development for Global Health, Quantoom Biosciences, UNIZIMA, and EXOTHERA. Previous roles include Executive Director at Lion's Head Global Partners and a Board Member for the Stop TB Partnership. Kate's early career involved a position as a Portfolio Analyst at J.P. Morgan Asset Management. Academic credentials include degrees from the University of Oxford, Columbia University, and The London School of Economics and Political Science.